Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency.

Bangalore-Prakash P, Stunz LL, Mambetsariev N, Whillock AL, Hostager BS, Bishop GA.

Blood Adv. 2017 Dec 18;1(27):2712-2723. doi: 10.1182/bloodadvances.2017009670. eCollection 2017 Dec 26.

2.

TRAF3 deficiency promotes metabolic reprogramming in B cells.

Mambetsariev N, Lin WW, Wallis AM, Stunz LL, Bishop GA.

Sci Rep. 2016 Oct 18;6:35349. doi: 10.1038/srep35349.

3.

Nuclear TRAF3 is a negative regulator of CREB in B cells.

Mambetsariev N, Lin WW, Stunz LL, Hanson BM, Hildebrand JM, Bishop GA.

Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):1032-7. doi: 10.1073/pnas.1514586113. Epub 2016 Jan 11.

4.

The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development.

Lin WW, Yi Z, Stunz LL, Maine CJ, Sherman LA, Bishop GA.

Sci Signal. 2015 Sep 1;8(392):ra88. doi: 10.1126/scisignal.aaa5157.

5.

The adaptor TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating signaling via the receptor for IL-2.

Yi Z, Lin WW, Stunz LL, Bishop GA.

Nat Immunol. 2014 Sep;15(9):866-74. doi: 10.1038/ni.2944. Epub 2014 Jul 20.

6.

TRAF3 regulates homeostasis of CD8+ central memory T cells.

Yi Z, Stunz LL, Lin WW, Bishop GA.

PLoS One. 2014 Jul 10;9(7):e102120. doi: 10.1371/journal.pone.0102120. eCollection 2014.

7.

Latent membrane protein 1 and the B lymphocyte-a complex relationship.

Stunz LL, Bishop GA.

Crit Rev Immunol. 2014;34(3):177-98. Review.

PMID:
24941072
8.

CD40-mediated maintenance of immune homeostasis in the adipose tissue microenvironment.

Yi Z, Stunz LL, Bishop GA.

Diabetes. 2014 Aug;63(8):2751-60. doi: 10.2337/db13-1657. Epub 2014 Mar 19.

9.

A new model of LMP1-MYC interaction in B cell lymphoma.

Ontiveros EP, Halwani A, Stunz LL, Kamberos N, Olivier AK, Janz S, Bishop GA.

Leuk Lymphoma. 2014 Dec;55(12):2917-23. doi: 10.3109/10428194.2014.900762. Epub 2014 Apr 23.

10.

Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Yi Z, Lin WW, Stunz LL, Bishop GA.

Cytokine Growth Factor Rev. 2014 Apr;25(2):147-56. doi: 10.1016/j.cytogfr.2013.12.002. Epub 2013 Dec 25. Review.

11.

TRAF6 is a critical regulator of LMP1 functions in vivo.

Arcipowski KM, Stunz LL, Bishop GA.

Int Immunol. 2014 Mar;26(3):149-58. doi: 10.1093/intimm/dxt052. Epub 2013 Oct 29.

12.

Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells.

Han SS, Tompkins VS, Son DJ, Kamberos NL, Stunz LL, Halwani A, Bishop GA, Janz S.

Biochem Biophys Res Commun. 2013 Jul 12;436(4):660-5. doi: 10.1016/j.bbrc.2013.06.012. Epub 2013 Jun 11.

13.

TNF receptor associated factor 3 plays a key role in development and function of invariant natural killer T cells.

Yi Z, Stunz LL, Bishop GA.

J Exp Med. 2013 Jun 3;210(6):1079-86. doi: 10.1084/jem.20122135. Epub 2013 May 6.

14.

Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Hildebrand JM, Yi Z, Buchta CM, Poovassery J, Stunz LL, Bishop GA.

Immunol Rev. 2011 Nov;244(1):55-74. doi: 10.1111/j.1600-065X.2011.01055.x. Review.

15.

Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes.

Xie P, Poovassery J, Stunz LL, Smith SM, Schultz ML, Carlin LE, Bishop GA.

J Leukoc Biol. 2011 Dec;90(6):1149-57. doi: 10.1189/jlb.0111044. Epub 2011 Oct 4.

16.

Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).

Arcipowski KM, Stunz LL, Graham JP, Kraus ZJ, Vanden Bush TJ, Bishop GA.

J Biol Chem. 2011 Mar 25;286(12):9948-55. doi: 10.1074/jbc.M110.185983. Epub 2011 Jan 24.

17.

TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling.

Xie P, Kraus ZJ, Stunz LL, Liu Y, Bishop GA.

J Immunol. 2011 Jan 1;186(1):143-55. doi: 10.4049/jimmunol.1000290. Epub 2010 Nov 17.

18.

Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice.

Peters AL, Stunz LL, Meyerholz DK, Mohan C, Bishop GA.

J Immunol. 2010 Oct 1;185(7):4053-62. doi: 10.4049/jimmunol.0904065. Epub 2010 Sep 1.

19.

CD40 and autoimmunity: the dark side of a great activator.

Peters AL, Stunz LL, Bishop GA.

Semin Immunol. 2009 Oct;21(5):293-300. doi: 10.1016/j.smim.2009.05.012. Review.

20.

Roles of TRAF molecules in B lymphocyte function.

Xie P, Kraus ZJ, Stunz LL, Bishop GA.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):199-207. doi: 10.1016/j.cytogfr.2008.04.002. Epub 2008 May 21. Review.

21.

A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.

Rowland SL, Tremblay MM, Ellison JM, Stunz LL, Bishop GA, Hostager BS.

J Immunol. 2007 Oct 1;179(7):4645-53.

22.
23.

TRAF proteins in CD40 signaling.

Bishop GA, Moore CR, Xie P, Stunz LL, Kraus ZJ.

Adv Exp Med Biol. 2007;597:131-51. Review.

PMID:
17633023
24.

Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture.

Stunz LL, Busch LK, Munroe ME, Sigmund CD, Tygrett LT, Waldschmidt TJ, Bishop GA.

Immunity. 2004 Aug;21(2):255-66.

25.

Antigen-specific B-lymphocyte activation.

Bishop GA, Haxhinasto SA, Stunz LL, Hostager BS.

Crit Rev Immunol. 2003;23(3):149-97. Review.

PMID:
14584878
26.

Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells.

Lenert P, Yi AK, Krieg AM, Stunz LL, Ashman RF.

Antisense Nucleic Acid Drug Dev. 2003;13(3):143-50.

PMID:
12954114
27.

Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells.

Stunz LL, Lenert P, Peckham D, Yi AK, Haxhinasto S, Chang M, Krieg AM, Ashman RF.

Eur J Immunol. 2002 May;32(5):1212-22.

28.

Difference in apoptosis induction between surface IgD and IgM.

Peckham D, Andersen-Nissen E, Finkelman FD, Stunz LL, Ashman RF.

Int Immunol. 2001 Mar;13(3):285-95.

PMID:
11222497
29.

Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13.

Kovar J, Stunz LL, Stewart BC, Kriegerbeckova K, Ashman RF, Kemp JD.

Pathobiology. 1997;65(2):61-8.

PMID:
9253029
30.

Fc receptor off-signal in the B cell involves apoptosis.

Ashman RF, Peckham D, Stunz LL.

J Immunol. 1996 Jul 1;157(1):5-11.

PMID:
8683155
31.

Regulation of B cell apoptosis.

Ashman RF, Peckham D, Stunz LL.

Adv Exp Med Biol. 1996;406:145-54. Review. No abstract available.

PMID:
8910681
32.

Membrane unpacking and the rapid disposal of apoptotic cells.

Ashman RF, Peckham D, Alhasan S, Stunz LL.

Immunol Lett. 1995 Dec;48(3):159-66.

PMID:
8867846
33.

Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis.

Mower DA Jr, Peckham DW, Illera VA, Fishbaugh JK, Stunz LL, Ashman RF.

J Immunol. 1994 May 15;152(10):4832-42.

PMID:
8176206
34.

Regulation of apoptosis in vitro in mature murine spleen T cells.

Perandones CE, Illera VA, Peckham D, Stunz LL, Ashman RF.

J Immunol. 1993 Oct 1;151(7):3521-9.

PMID:
8376790
35.

Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4.

Illera VA, Perandones CE, Stunz LL, Mower DA Jr, Ashman RF.

J Immunol. 1993 Sep 15;151(6):2965-73.

PMID:
8376764
36.
37.

Two mechanisms of transferrin receptor induction by anti-Ig in B cells.

Vora A, Stunz LL, Kemp JD, Ashman RF.

J Immunol. 1990 Oct 1;145(7):2099-104.

PMID:
2168917
38.

HLA-DRB1 and -DRB4 genes are differentially regulated at the transcriptional level.

Stunz LL, Karr RW, Anderson RA.

J Immunol. 1989 Nov 1;143(9):3081-6.

PMID:
2809218
40.

A specific estrogen receptor in the mouse spleen. Characterization and evidence of physiological regulation.

West NB, Anderson DJ, Stunz LL, Hoch EJ.

J Steroid Biochem. 1982 Apr;16(4):557-62.

PMID:
7087479

Supplemental Content

Loading ...
Support Center